Allied(OTC) ALID

Market Cap$100.00

Since IPO (2019)-100%

5 Year-100%

1 Year-100%

1 Month+0%

$0.00

+0.00%

+0.00Today

Allied last closing stock price
Metric	Price	Date
Last close	USD 0.00	2026-08-06

Allied stock price return by period
Period	Price return	Price at period start	Period start date
1 week	+0%	USD 0.00	2026-07-15
1 month	+0%	USD 0.00	2026-05-27
3 month	+0%	USD 0.00	2026-03-02
Year to date	-99.8%	USD 0.00	2025-12-29
1 year	-99.99%	USD 0.01	2025-08-05
3 year	-100%	USD 0.25	2023-08-07
5 year	-100%	USD 1.01	2021-08-06
Since inception	-100%	USD 1.44	2019-09-11

Allied Financials at a Glance

Market Cap

$100.00

Revenue (TTM)

$72.10K

Net Income (TTM)

-$10.88M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-568.29 (Low)

Dividend

$0.00

Beta (Volatility)

-568.29 (Low)

Price

$0.00

Volume

200

Open

$0.00

Price

$0.00

Volume

200

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.01

Estimated Earnings Date

N/A

Dividend

$0.00

Beta (Volatility)

-568.29 (Low)

Price

$0.00

Volume

200

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.01

Estimated Earnings Date

N/A

ALID News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Allied

Allied Corp. specializes in the research, development, and production of cannabinoid health solutions, primarily operating in the United States. The company markets a diverse portfolio of natural health products derived from hemp under various brands.

Products and Services

Natural health products including CBD tinctures and gummies
Specialized skincare line featuring various topical formulations
Pharmaceutical development with experimental drug candidates for PTSD

Growth Outlook

Expansion into new markets anticipated to drive revenue growth
Continued investment in R&D for innovative cannabinoid solutions
Increasing consumer demand for natural health products supports market potential

Financial Highlights

Recent quarterly revenue of $2,471 reflects ongoing operational challenges
Trailing twelve months (TTM) net income shows significant losses, indicating need for strategic adjustments
Cash at end of Q4 2023 increased to $209,736, improving liquidity position

Allied Corp. operates in the rapidly evolving cannabinoid health sector, focusing on innovative products that cater to consumer wellness. The company's diverse offerings, including its Tactical Relief and Equilibrium Bio brands, position it well within the market. Despite recent financial challenges, including a TTM net income loss, the company is poised for potential growth through strategic market expansion and continued investment in research and development. The increasing consumer interest in natural health solutions further enhances the company's market prospects.

AI Generated • Jul 27, 2026

Industry

Pharmaceuticals

Sector

Health Care

Employees

CEO

Calum Hughes, PhD

Website

allied.health

Headquarters

Kelowna, BC V1Y OC2, CA

ALID Financials

Key Financial Metrics (TTM)

Gross Margin

-2027.53%

Operating Margin

-14235.43%

Net Income Margin

-14807.58%

Return on Equity

261.44%

Return on Capital

N/A

Return on Assets

-517.30%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$100.00

Shares Outstanding

115.50M

Volume

200

Avg. Volume

22.413

Financials (TTM)

Gross Profit

-$1.54M

Operating Income

-$7.56M

EBITDA

-$7.47M

Operating Cash Flow

-$1.96M

Capital Expenditure

-$87.80K

Free Cash Flow

-$2.04M

Cash & ST Invst.

$209.74K

Total Debt

$5.86M

Allied Performance Analysis

Allied annual revenue and year-over-year revenue growth by fiscal year
Fiscal year	Period end	Revenue	YoY growth
2021	2021-08-31	USD 16,036	N/A
2022	2022-08-31	USD 165,596	932.7%
2023	2023-08-31	USD 72,096	-56.5%
2024	2024-08-31	USD 96,180	33.4%

Allied sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q1	2022-11-30	-40.2%
Q2	2023-02-28	-100.0%
Q3	2023-05-31	N/A
Q4	2023-08-31	N/A

Allied annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal year	Period end	Diluted EPS	YoY growth
2021	2021-08-31	USD -0.14	N/A
2022	2022-08-31	USD -0.17	18.1%
2023	2023-08-31	USD -0.11	-34.6%
2024	2024-08-31	USD -0.04	-65.9%

Allied sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q1	2022-11-30	-52.4%
Q2	2023-02-28	-35.7%
Q3	2023-05-31	-4.7%
Q4	2023-08-31	-138.1%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2023YOY CHG

Revenue

$2.47K

-97.9%

Gross Profit

-$1.51M

-2355.4%

Gross Margin

-609.24%

N/A

Market Cap

$100.00

N/A

Market Cap/Employee

$0.67

N/A

Employees

150

N/A

Net Income

-$5.14M

-520.0%

EBITDA

-$2.29M

-106.2%

Quarterly Fundamentals

Name

Q4 2023YOY CHG

Total Cash

$209.74K

+118.4%

Total Debt

$5.86M

+15.4%

Accounts Receivable

$134.48K

+10.8%

Inventory

$107.51K

-89.2%

Long Term Debt

$98.56K

-40.1%

Short Term Debt

$5.76M

+17.2%

Return on Assets

-5.17%

N/A

Return on Invested Capital

1.51%

N/A

Free Cash Flow

$51.10K

+105.1%

Operating Cash Flow

$53.36K

+105.2%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

SRUTFSproutly Canada Inc.

SRUTFSproutly Canada Inc.$0.00+0.00%

MSTHMystic Holdings, Inc.

MSTHMystic Holdings, Inc.$0.00+0.00%

PHBIPharmagreen Biotech Inc.

PHBIPharmagreen Biotech Inc.$0.00+12.50%

CBDYTarget Group Inc.

CBDYTarget Group Inc.$0.00+0.00%

MJNAMedical Marijuana, Inc.

MJNAMedical Marijuana, Inc.$0.00+0.00%

CPMDCannaPharmaRX, Inc.

CPMDCannaPharmaRX, Inc.$0.00+0.00%

EXMTAnything Technologies Media, Inc.

EXMTAnything Technologies Media, Inc.$0.00+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

SPCXSpace Exploration Technologies

SPCXSpace Exploration Technologies$114.92+0.06%

NVDANvidia

NVDANvidia$218.99-0.00%

TTDThe Trade Desk

TTDThe Trade Desk$17.67-0.07%

SOUNSoundHound AI

SOUNSoundHound AI$7.08+0.10%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$7.68-0.01%

INTCIntel

INTCIntel$99.81-0.01%

PATHUiPath

PATHUiPath$14.00+0.01%

Questions About ALID

What is the current price of Allied?

Allied is trading at $0.00 per share.

What is the 52-week range for Allied?

Over the past 52 weeks, Allied has traded between $0.00 and $0.01.

How much debt does Allied have?

As of the most recent reporting period, Allied reported total debt of $6.61M.

How much cash does Allied have on hand?

Allied reported $359.10K in cash and cash equivalents in its most recent financial results.

What is Allied’s dividend yield?

Allied does not currently have a dividend yield.

Allied(OTC) ALID

Allied Financials at a Glance

ALID News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Allied

ALID Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Allied Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About ALID

What is the current price of Allied?

What is the 52-week range for Allied?

How much debt does Allied have?

How much cash does Allied have on hand?

What is Allied’s dividend yield?

Premium Investing Services